XML 83 R71.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Information by segment and main country - Information on income statements (Detail) - EUR (€) € in Millions | 12 Months Ended
--- | ---
Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017
Information by segment and main country - Text Details (Detail) [Line Items] |  |  |  |  |  |  |
Revenue |  | € 19,482 | [1] | € 18,121 | [2] | € 17,780 |
Sales including intercompany |  | 19,482 |  | 18,121 |  | 17,780 |
Depreciation and amortisation expense | [4] | 1,402 | [3] | 1,089 | [5] | 1,025 | [3]
Adjusted EBITA | [6] | 2,563 | [7] | 2,366 | [7] | 2,153 | [8]
Connected Care [Member] |  |  |  |  |  |  |
Information by segment and main country - Text Details (Detail) [Line Items] |  |  |  |  |  |  |
Revenue |  | 4,674 | [9] | 4,341 | [2] | 4,331 |
Sales including intercompany |  | 4,760 |  | 4,516 |  | 4,492 |
Depreciation and amortisation expense | [4] | 327 |  | 326 |  | 355 |
Adjusted EBITA | [6] | 618 | [7] | 662 | [8] | 684 | [8]
Diagnosis & Treatment [Member] |  |  |  |  |  |  |
Information by segment and main country - Text Details (Detail) [Line Items] |  |  |  |  |  |  |
Revenue |  | 8,485 | [9],[10] | 7,726 | [2] | 7,365 |
Sales including intercompany |  | 8,579 | [10] | 7,825 |  | 7,445 |
Depreciation and amortisation expense | [4] | 564 | [10] | 349 |  | 301 |
Adjusted EBITA | [6],[7] | 1,078 | [10] | 872 |  | 747 |
Intersector Eliminations [member] |  |  |  |  |  |  |
Information by segment and main country - Text Details (Detail) [Line Items] |  |  |  |  |  |  |
Sales including intercompany |  | (263) |  | (369) |  | (393) |
Other [Member] |  |  |  |  |  |  |
Information by segment and main country - Text Details (Detail) [Line Items] |  |  |  |  |  |  |
Revenue |  | 469 | [9] | 530 | [2] | 400 |
Sales including intercompany |  | 542 |  | 612 |  | 535 |
Depreciation and amortisation expense | [4] | 326 |  | 244 |  | 188 |
Adjusted EBITA | [6] | (76) | [8] | (28) | [8] | (157) | [7]
Personal Health [Member] |  |  |  |  |  |  |
Information by segment and main country - Text Details (Detail) [Line Items] |  |  |  |  |  |  |
Revenue |  | 5,854 | [9] | 5,524 | [2] | 5,685 |
Sales including intercompany |  | 5,864 |  | 5,538 |  | 5,702 |
Depreciation and amortisation expense | [4] | 186 |  | 171 |  | 181 |
Adjusted EBITA | [6] | € 943 | [7] | € 860 | [7] | € 879 | [8]
[1] | Represents revenue from external customers as required by IFRS 8 Operating Segments.
[2] | Represents revenue from external customers as required by IFRS 8 Operating Segments.
[3] | Impact of IFRS 16 adoption. Reference is made to Significant accounting policies and Property, plant and equipment
[4] | Includes impairments; for impairment values please refer to Property, plant and equipment and Intangible assets excluding goodwill
[5] | Impact of IFRS 16 adoption. Reference is made to Significant accounting policies and Property, plant and equipment
[6] | For reconciliation Adjusted EBITA, refer to the table below.
[7] | Non-IFRS financial measure. For the definition and reconciliation of the most directly comparable IFRS measure, refer to Reconciliation of non-IFRS information.
[8] | Non-IFRS financial measure. For the definition and reconciliation of the most directly comparable IFRS measure, refer to Reconciliation of non-IFRS information.
[9] | Represents revenue from external customers as required by IFRS 8 Operating Segments.
[10] | In 2019 Philips’ Emerging Businesses were moved out of segment Other into segment Diagnosis & Treatment to enable these businesses with better access to downstream capabilities. While these businesses remain in (semi-)incubator phase, in 2019 they received a corporate funding out of segment Other of EUR 54 million to support them during their emerging idea-to-market business phase.

X
- Definition The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2019-01-01 -Paragraph 23 -Subparagraph e -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2019-en-r&anchor=para_23_e&doctype=Standard -URIDate 2019-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2019-01-01 -Paragraph 28 -Subparagraph e -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2019-en-r&anchor=para_28_e&doctype=Standard -URIDate 2019-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2019-01-01 -Paragraph B13 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2019-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B -URIDate 2019-03-27 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2019-01-01 -Paragraph 102 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2019-en-r&anchor=para_102&doctype=Standard -URIDate 2019-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2019-01-01 -Paragraph 99 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2019-en-r&anchor=para_99&doctype=Standard -URIDate 2019-03-27 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2019-01-01 -Paragraph 104 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2019-en-r&anchor=para_104&doctype=Standard -URIDate 2019-03-27 + Details
Name: | ifrs-full_DepreciationAndAmortisationExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Expiry date 2020-01-01: The income arising in the course of an entity's ordinary activities. Income is increases in economic benefits during the accounting period in the form of inflows or enhancements of assets or decreases of liabilities that result in an increase in equity, other than those relating to contributions from equity participants. Effective 2020-01-01: The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2019-01-01 -Paragraph 28 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2019-en-r&anchor=para_28_a&doctype=Standard -URIDate 2019-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2019-01-01 -Paragraph 23 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2019-en-r&anchor=para_23_a&doctype=Standard -URIDate 2019-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2019-01-01 -Paragraph 32 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2019-en-r&anchor=para_32&doctype=Standard -URIDate 2019-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2019-01-01 -Paragraph 33 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2019-en-r&anchor=para_33_a&doctype=Standard -URIDate 2019-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2019-01-01 -Paragraph 34 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2019-en-r&anchor=para_34&doctype=Standard -URIDate 2019-03-27 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2019-01-01 -Paragraph 82 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2019-en-r&anchor=para_82_a&doctype=Standard -URIDate 2019-03-27 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2019-01-01 -Paragraph 103 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2019-en-r&anchor=para_103&doctype=Standard -URIDate 2019-03-27 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2019-01-01 -Paragraph 102 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2019-en-r&anchor=para_102&doctype=Standard -URIDate 2019-03-27 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 5 -IssueDate 2019-01-01 -Paragraph 33 -Subparagraph b -Clause i -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2019-en-r&anchor=para_33_b_i&doctype=Standard -URIDate 2019-03-27 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2019-01-01 -Paragraph B12 -Subparagraph b -Clause v -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2019-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B -URIDate 2019-03-27 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 12 -IssueDate 2019-01-01 -Paragraph B10 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2019-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B -URIDate 2019-03-27 + Details
Name: | ifrs-full_Revenue
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_AdjustedEBITA
Namespace Prefix: | phg_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_InformationBySegmentAndMainCountryLineItems
Namespace Prefix: | phg_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_SalesIncludingIntercompany
Namespace Prefix: | phg_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_SegmentsAxis=phg_ConnectedCareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=phg_DiagnosisAndTreatmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=phg_IntersectorEliminationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=phg_OtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=phg_PersonalHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |